The committee also wants the FDA to review some BHT therapies as candidates for the Unfortunately, but perhaps understandably in light of the pandemic, I cannot find that the National Academies report has been picked up by the mainstream media, despite its importance to the thousands of patients who are prescribed cBHT, unaware of the lack of evidence and health risks. cBHT preparations . For starters:Many patients believe that bioidentical means that plants are the source of the hormones, however, it is the chemical structure and not the source that determines whether a hormone is bioidentical.
Based on the available research, the report concludes that drivers of patient interest in, and use of, cBHT, may include unsubstantiated marketing claims of superior safety and effectiveness from compounding pharmacies, medical clinics, and “wellness clinics”, amplified by social media and celebrity endorsements; “boutique patient experience”; mistrust in the healthcare and pharmaceutical industries; and the appeal of “natural” hormones and/or dosage forms.Interestingly, the committee found that, despite healthcare provider claims of “customized” and “personalized” cBHT formulations,compounders often offer preprinted prescription pads for cBHT with a checklist of popular ingredient combinations, concentrations, and dosage forms. Bioidentical Hormones and Skin. Remedy Compounded bioidentical hormones fall under this regulation, and has become a growing focus of concern from many professional medical organizations, with virtually every medical society providing guidance to clinicians recommending against prescribing cBHT, 3,4 according to the authors. This information is not designed to replace a physician's independent judgment about the appropriateness or
Because of these limitations, different compounders may use different processes to compound an identical prescription, and as a result, cBHT preparations ordered with identical prescriptions and labeled with the same name will likely vary between compounders. Bioidentical hormone replacement therapy (BHRT) is not without controversy, but it may be a good option for you. compounded bioidentical hormones in making their case for advising patients to avoid these pharmacy-designed products over traditional hormone replacement therapy.Their concerns — similar to cautions raised with dietary supplements — are as follows:Compounded bioidentical hormones fall under this regulation, and has become a growing focus of concern from many professional medical organizations, with virtually every Drs.
Compounded bioidentical hormones (cBHT) are risky at best and most likely hazardous, and should be regulated by the Food and Drug Administration just as other menopausal hormone therapy products are,These two internationally recognized experts in women’s health, both of whom are past presidents of the North American Menopause Society, raised a warning about the hazards that should be heeded by clinicians, including endocrinologists, before writing another prescription for compounded bioidentical hormone replacement therapy, in a commentary published in Dr. Manson and Dr. Stuenkel have been attempting to draw heightened attention to consequences of using these compounded hormone products for quite a while, and to express the urgency in making endocrinologists, primary care physicians, and women aware of the concerns to arrest further prescribing of cBHT.
Their report, some 350 pages long, details the committee’s findings and makes recommendations, including restricting the use of cBHT preparations.hormones that are chemically and structurally identical to those produced by the human body, with the The vast majority of FDA-approved BHT products are indicated for treating symptoms of menopause and male hypogonadism, and the report focuses on cBHT use for these indications as well.